Small angle X-ray diffraction (SAXD) and electron microscopy (EM) of membranes enriched in acetylcholine receptor (AcChR) have produced 20-30 angstrom-resolution three-dimensional models of the AcChR. Our unique library of anti-AcChR monoclonal antibodies (mAbs) define a set of epitopes on the AcChR each of which mark a functionally sensitive site. We propose to map these epitopes onto the three-dimensional model of the AcChR using SAXD and EM analysis of AcChR complexed to the mAbs or their Fab fragments. As we identify the amino acid residues comprising the epitopes for the mAbs in Project 5, our Fab locations will serve to map the residues onto AcChR subregions of dimensions (13 x 6 x 15 angstrom). In addition, we propose to localize the bromoacetylcholine affinity site of the AcChR, along with a second sulfhydryl site, by analyzing fluorescent dyes covalently attached to these two sites. The distance between these sites, and others, will be determined by resonance energy transfer. In addition, mAbs directed against the dyes will be used to identify their sites of attachment on the three-dimensional model of the AcChR. Hence, these studies will have mapped portions of the primary structure of the AcChR onto the model of its tertiary structure.

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Fairclough, R H; Twaddle, G M; Gudipati, E et al. (1998) Mapping the mAb 383C epitope to alpha 2(187-199) of the Torpedo acetylcholine receptor on the three-dimensional model. J Mol Biol 282:301-15
Fairclough, R H; Twaddle, G M; Gudipati, E et al. (1998) Differential surface accessibility of alpha(187-199) in the Torpedo acetylcholine receptor alpha subunits. J Mol Biol 282:317-30
Richman, D P; Agius, M A; Kirvan, C A et al. (1998) Antibody effector mechanisms in myasthenia gravis. The complement hypothesis. Ann N Y Acad Sci 841:450-65
Fairclough, R H; Gudipati, E; Lin, M Y et al. (1998) A role for alpha(187-199) in the conversion of agonist binding energy to the opening of the acetylcholine receptor ion channel. Ann N Y Acad Sci 841:87-92
Richman, D P; Agius, M A (1994) Acquired myasthenia gravis. Immunopathology. Neurol Clin 12:273-84
Richman, D P; Agius, M A (1994) Myasthenia gravis: pathogenesis and treatment. Semin Neurol 14:106-10
Fairclough, R H; Josephs, R; Richman, D P (1993) Imaging ligand binding sites on the Torpedo acetylcholine receptor. Ann N Y Acad Sci 681:113-25
Xu, Q; Agius, M; Gudipati, E et al. (1993) An immunogenic self-peptide for T cells in mice with experimental myasthenia. Ann N Y Acad Sci 681:1-4
Xu, Q; Twaddle, G M; Richman, D P et al. (1993) Characterization of the epitope of an antiacetylcholine receptor antibody that inhibits fifty percent of alpha-bungarotoxin binding. Ann N Y Acad Sci 681:175-8
Xu, Q; Fairclough, R H; Richman, D P (1993) Interaction of antiacetylcholine receptor monoclonal antibodies with the acetylcholine receptor. Ann N Y Acad Sci 681:172-4

Showing the most recent 10 out of 16 publications